SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Suven Life Sciences board to consider un-audited financial results

02 Nov 2015 Evaluate

Suven Life Sciences has informed that a Board Meeting of our Company will be held on November 10, 2015, to consider and take on record the Un-audited Financial Results for the second quarter ended September 30, 2015. Further, the Trading Window for dealing in the securities of the company is closed from November 02, 2015 to November 12, 2015. Trading window will be opened from November 13, 2015.

The above information is a part of company’s filings submitted to BSE.

Suven Life Sciences Share Price

215.00 19.10 (9.75%)
20-Apr-2026 10:28 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.25
Dr. Reddys Lab 1235.65
Cipla 1237.60
Zydus Lifesciences 940.00
Lupin 2327.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×